Characterization of the ovine ortholog of secretory leukoprotease inhibitor

Mammalian Genome

Volumn 16, Issue 8, 2005, Pages 621-630

  Brown, Thomas I ^a,b   Mistry, Rohit ^c   Gray, Robert ^d   Imrie, Margaret ^d   Collie, David D ^b   Sallenave, Jean Michel ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; ISOPROTEIN; LEUKOCYTE ELASTASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE SEQUENCE; GENETIC CODE; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; INTESTINE; KIDNEY; LIVER; MAMMAL; MOLECULAR CLONING; MUCOSA; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SURFACE PROPERTY; TISSUE DISTRIBUTION; UPPER RESPIRATORY TRACT; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CULTURE MEDIA, CONDITIONED; LEUKOCYTE ELASTASE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RNA, MESSENGER; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SEQUENCE HOMOLOGY; SHEEP, DOMESTIC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBCELLULAR FRACTIONS;

MAMMALIA; MURINAE; OVIS; OVIS ARIES; SUIDAE;

EID: 25144455947     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-005-0030-2     Document Type: Article

References (28)

1. Boudier C, Bieth JG (1992) The proteinase:mucus proteinase inhibitor stoichiometry. J Biol Chem 267, 4370-4375
2. Brown TI, Mistry R, Collie D, Tate S, Sallenave J-M (2004) Trappin ovine molecule (TOM), the ovine ortholog of elafin, is an acute phase reactant in the lung. Physiol Genomics 19, 11-21
3. Eisenberg SP, Hale KK, Heimdal P, Thompson RC (1990) Location of the protease-inhibitory region of secretory leukoprotease inhibitor. J Biol Chem 265, 7976-7981
4. Farmer SJ, Fliss AE, Simmen RC (1990) Complementary DNA cloning and regulation of expression of the messenger RNA encoding a pregnanacy-associated porcine uterine protein related to human antileukoproteinase. Mol Endocrinol 4, 1095-1104
5. Franken C, Meijer CJ, Dijkman JH (1989) Tissue distribution of antileukoprotease and lysozyme in humans. J Histochem Cytochem 37, 493-498
6. Gross P, Pfitzer E, Tolker E, Babyak M, Kaschak M (1965) Experimental emphysema: its production with papain in normal and silicotic rats. Arch Environ Health 11, 50-58
7. Grutter MG, Fendrich G, Huber R, Bode W (1988) The 2.5 X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin. EMBO J 7, 345-351
8. Heinzel R, Appelhans H, Gassen G, Seemuller U, Machleidt W, et al. (1986) Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. Eur J Biochem 160, 61-67
9. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, et al. (1996) Antibacterial activity of antileukoprotease. Infect Immun 64, 4520-4524
10. Jin FY, Nathan C, Radzioch D, Ding A (1997) Secretory leukoprotease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. 88, 417-426
11. Laurell CB, Erikkson S (1963) Electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 15, 132-140
12. Nara K, Ito S, Ito T, Suzuki Y, Ghoneim MA, et al. (1994) Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin". J Biochem (Tokyo) 115, 441-448
13. Ohlsson S, Ljungkrantz I, Ohlsson K, Segelmark M, Wieslander J (2001) Novel distribution of the secretory leukocyte proteinase inhibitor in kidney. Mediators Inflamm 10, 347-350
14. Rudolphus A, Stolk J, Dijkman JH, Kramps JA (1993) Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am Rev Respir Dis 147, 442-447
15. Sallenave J-M, Ryle AP (1991) Purification and characterization of elastase-specific inhibitor. Sequence homology with mucuc proteinase inhibitor. Biol Chem Hoppe Seyler 372, 13-21
16. Sallenave J-M, Silva A, Marsden ME, Ryle A (1993) Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am J Respir Cell Mol Biol 8, 126-133
17. Schalkwijk J, Wiedow O, Hirose S (1999) The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem J 340, 569-577
18. Seemuller U, Arnhold M, Fritz H, Wiedenmann K, Machleidt W, et al. (1986) The acid-stable proteinase inhibitor of human mucus secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor. FEBS Lett 199, 43-48
19. Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave J-M (1999) Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett 452, 309-313
20. Song X, Zeng L, Jin W, Thompson J, Mizel DE, et al. (1999) Secretory leukocyte proteinase inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med 190, 535-542
21. Sponer M, Nick HP, Schnebli HP (1991) Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa. Biol Chem Hoppe Seyler 372, 963-970
22. Stetler G, Brewer MT, Thompson RC (1986) Isolation and sequence of a gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Res 14, 7883-7896
23. Stolk J, Rudolphus A, Kramps JA (1991) Lipopolysaccharide-induced alveolar wall destruction in the hamster is inhibited by intratracheal treatment with r-secretory leukoprotease inhibitor. Ann N Y Acad Sci 624, 350-352
24. Taggart CC, Greene CM, McElvaney NG, O'Neill S (2002) Secretory leukoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination. J Biol Chem 277, 33648-33653
25. Thompson RC, Ohlsson K (1986) Isolation, properties and complete amino acid sequence of human secretory leukoprotease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A 83, 6692-6696
26. Tomee JF, Hiemstra PS, Heinzel-Wieland R, Kauffman HF (1997) Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis 176, 740-747
27. Tsunemi M, Matsuura Y, Sakakibara S, Katsube Y (1996) Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 resolution. Biochemistry 35, 11570-11576
28. Zitnik RJ, Zhang J, Kashem MA, Kohno T, Lyons DE, et al. (1997) The cloning and characterization of a murine secretory leukocyte proteinase inhibitor cDNA. Biochem Biophys Res Commun 232, 687-697